Creative Planning’s BeOne Medicines Ltd ONC Stock Holding History

Creative Planning’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.62M	Buy	12,703 +2,545	+25%	+$750K	﹤0.01%	1647
2026 Q1	$3.02M	Buy	10,158 +892	+10%	+$289K	﹤0.01%	1570
2025 Q4	$2.82M	Buy	9,266 +315	+4%	+$103K	﹤0.01%	1430
2025 Q3	$3.05M	Buy	8,951 +2,970	+50%	+$902K	﹤0.01%	1209
2025 Q2	$1.45M	Buy	5,981 +2,666	+80%	+$654K	﹤0.01%	1563
2025 Q1	$902K	Buy	3,315 +2,412	+267%	+$564K	﹤0.01%	1790
2024 Q4	$167K	Buy	+903	New	+$184K	﹤0.01%	3027
2018 Q2	–	Sell	-2,503	Closed	-$421K	–	2188
2018 Q1	$421K	Buy	2,503 +3	+0.1%	+$406	﹤0.01%	1165
2017 Q4	$244K	Hold	2,500	–	–	﹤0.01%	1478
2017 Q3	$259K	Buy	2,500 +1,000	+67%	+$74.5K	﹤0.01%	1430
2017 Q2	$68K	Buy	+1,500	New	+$59.1K	﹤0.01%	2280

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Creative Planning's ONC Position: Q2 2026 in Review

Creative Planning increased its BeOne Medicines Ltd (ONC) stake by 25% in Q2 2026, buying an estimated $750K and bringing the position to 12,703 shares worth $3.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1647.

Creative Planning first reported a position in ONC in Q2 2017 and has held it in 11 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Creative Planning held 12,703 shares of BeOne Medicines Ltd worth $3.62M as of Q2 2026.
Creative Planning bought 2,545 BeOne Medicines Ltd shares in Q2 2026, an estimated $750K.
BeOne Medicines Ltd made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #1647 holding.
Creative Planning first reported a position in BeOne Medicines Ltd in Q2 2017 and has held it in 11 quarters since.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.